Diversified Healthcare Q2 2024 FFO $0.03 Beats $0.02 Estimate, Sales $371.392M Miss $372.130M Estimate
Portfolio Pulse from Benzinga Newsdesk
Diversified Healthcare (NASDAQ:DHC) reported Q2 2024 earnings per share of $0.03, beating the analyst estimate of $0.02 by 50%. However, their sales of $371.392 million missed the estimate of $372.130 million by 0.20%. This represents a 7.27% increase over the same period last year.
August 01, 2024 | 8:55 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Diversified Healthcare (NASDAQ:DHC) reported Q2 2024 earnings per share of $0.03, beating the analyst estimate of $0.02 by 50%. However, their sales of $371.392 million missed the estimate of $372.130 million by 0.20%. This represents a 7.27% increase over the same period last year.
The earnings per share (EPS) beat by 50% is a positive indicator and likely to boost investor confidence. The slight miss in sales is relatively minor and offset by the 7.27% year-over-year increase in sales, which is a positive growth indicator.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100